View on Pubmed.gov 34319520 | View on doi.org 10.1007/s11356-...
Microbiota and epigenetics: promising therapeutic approaches?
- Department of Medicine and Infectious Diseases, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
- Chrono-Environnement Laboratory, UMR CNRS 6249, Bourgogne Franche-Comté University, F-25030, Besançon Cedex, France.
- Department of Medicine and Infectious Diseases, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt. m_salah@staff.cu.edu.eg.
Abstract
The direct/indirect responsibility of the gut microbiome in disease induction in and outside the digestive tract is well studied. These results are usually from the overpopulation of certain species on the cost of others, interaction with beneficial microflora, interference with normal epigenetic control mechanisms, or suppression of the immune system. Consequently, it is theoretically possible to cure such disorders by rebalancing the microbiome inside our bodies. This can be achieved by changing the lifestyle pattern and diet or by supplementation with beneficial bacteria or their metabolites. Various approaches have been explored to manipulate the normal microbial inhabitants, including nutraceutical, supplementations with prebiotics, probiotics, postbiotics, synbiotics, and antibiotics, or through microbiome transplantation (fecal, skin, or vaginal microbiome transplantation). In the present review, the interaction between the microbiome and epigenetics and their role in disease induction is discussed. Possible future therapeutic approaches via the reestablishment of equilibrium in our internal micro-ecosystem are also highlighted.
References
Alang N, Kelly CR (2015) Weight gain after fecal microbiota transplantation, Open forum infectious diseases. Oxford University Press 2(1)
Al-Ghazzewi F, Tester R (2016) Biotherapeutic agents and vaginal health. J Appl Microbiol 121:18–27
Amato RJ (2007) Inhibition of DNA methylation by antisense oligonucleotide MG98 as cancer therapy. Clin Genitourin Cancer 5:422–426
Ambrose N, Allan R, Keighley M, Burdon D, Youngs D, Barnes P, Lennard-Jones J (1985) Antibiotic therapy for treatment in relapse of intestinal Crohn's disease. Dis Colon Rectum 28:81–85
Cited by 34 citations (total)
Journal Article Review
A multidisciplinary review of long COVID to address the challenges in diagnosis and updated management guidelines.
Electronic publication date April 11, 2025
Abbas Hamza Abbas [...] Ominat Amir Hussin et al.
Long COVID has emerged as a significant challenge since the COVID-19 pandemic, which was declared as an outbreak in March...
Journal Article Review
The Challenge of Long COVID-19 Management: From Disease Molecular Hallmarks to the Proposal of Exercise as Therapy.
Electronic publication date October 29, 2022
Raffaele Scurati [...] Cristina Tringali et al.
Long coronavirus disease 19 (COVID-19) is the designation given to a novel syndrome that develops within a few months after...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
- •
Substances
Copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.